Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascularization, Choroidal”

339 trials

Showing 20 of 339 results

Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Testing effectiveness (Phase 2)Ended earlyNCT00090532
What this trial is testing

The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Pfizer 155
Not applicableUnknownNCT02597855
What this trial is testing

Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Yeungnam University College of Medicine 29
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Not applicableStudy completedNCT03793400
What this trial is testing

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Who this might be right for
Choroidal NeovascularizationPunctate Inner Choroidopathy
Changhua Christian Hospital 22
Not applicableStudy completedNCT03459144
What this trial is testing

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 60
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Large-scale testing (Phase 3)Study completedNCT00090623
What this trial is testing

RhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 180
Not applicableUnknownNCT03838679
What this trial is testing

Imaging of the Angiofibrotic Switch in Neovascular AMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Medical University of Vienna 120
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Large-scale testing (Phase 3)Study completedNCT00058994
What this trial is testing

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Who this might be right for
Macular DegenerationMaculopathy, Age-Related
Alcon Research
Testing effectiveness (Phase 2)Study completedNCT01162746
What this trial is testing

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
Medical University of Vienna 40
Large-scale testing (Phase 3)Ended earlyNCT02769169
What this trial is testing

Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 5
Testing effectiveness (Phase 2)Study completedNCT02397954
What this trial is testing

Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation 4
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation